Table 5.
Characteristic | All Men (n = 571) |
Negative Biopsies (N = 197) |
Prostate Cancer (N = 374) |
|||
---|---|---|---|---|---|---|
OR (95 % CI) | p-value | OR (95 % CI) | p-value | OR (95 % CI) | p-value | |
Age at enrollment, years | 1.06 (1.03, 1.08) | < 0.001 | 1.12 (1.07, 1.18) | < 0.001 | 1.05 (1.02, 1.08) | 0.003 |
Serum 25-OH D < 30 ng/ml | 1.60 (1.06, 2.41) | 0.02 | 1.72 (0.79, 3.74) | 0.17 | 1.59 (0.96, 2.65) | 0.07 |
5-ARI use, yes | 2.98 (1.57, 5.65) | 0.001 | 2.40 (0.90, 6.41) | 0.08 | 2.05 (0.81, 5.20) | 0.13 |
Model controlling for all variables above and season of blood draw; covariates removed from model if p > 0.10;
Abbreviation: 5-ARI = 5-alpha reductase inhibitor, PSA = prostate specific antigen